2025. A preliminary study on the prognostic significance of cysteine-rich EGF ligand domain 2 protein (CRELD2) in patients with triple negative breast cancer. Biomolecules and Biomedicine. (Jan. 2025). DOI:https://doi.org/10.17305/bb.2024.11865.